Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low
The post Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low appeared on BitcoinEthereumNews.com. As of 8:19am today in New York, every retail investor who had ever bought shares of Enlivex on the Nasdaq, an arthritis biotech-turned-digital asset treasury (DAT), had lost money. The company bet its balance sheet on the RAIN crypto token that ZachXBT eventually tied to Moshe Hogeg, an Israeli entrepreneur facing a $290 million law enforcement investigation. Shares of Enlivex, which have been trading publicly for 12 years, traded to their all-time low of $0.42 this morning. Investors are slowly losing it all. Hogeg has denied fraud allegations via a spokesperson. The biotech company spent years developing clinical therapeutics. Bizarrely, it then reinvented itself in November 2025 to what it called the “world’s first prediction markets digital asset treasury strategy.” That was a world first — and probably last. The company raised over $200 million through a private plac